Skip to main content

Rheumatoid Arthritis News (Page 3)

Related terms: Arthritis, Arthritis, Rheumatoid, RA, Rheumatoid, Inflamed Joints

Urine Albumin-to-Creatinine Ratio Indicates Risk in Rheumatoid Arthritis

THURSDAY, Oct. 10, 2024 – For patients with rheumatoid arthritis (RA), urine albumin-to-creatinine ratio (ACR) is an independent risk factor indicating prognosis, according to a study published...

Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis

WEDNESDAY, Oct. 9, 2024 – Age-related macular degeneration (AMD) is associated with a higher risk for rheumatoid arthritis (RA), according to a study published online Sept. 9 in Scientific Reports. ...

Arthritis Can Flare Up in Colder Weather: Tips to Easing the Pan

FRIDAY, Sept. 20, 2024 – An arthritis sufferer’s joints start to get ornery when the weather turns colder, getting stiff and achy as the mercury drops. Cold weather doesn’t cause arthritis, but it ca...

CT-Based Radiomics Nomogram Can ID RA-Linked Interstitial Lung Disease

FRIDAY, Sept. 6, 2024 – A computed tomography (CT)-based radiomics nomogram model can achieve favorable efficacy for predicting low-risk patients with rheumatoid arthritis (RA)-associated...

Lung Complications + Rheumatoid Arthritis Increase Risk for Lung Cancer

FRIDAY, Sept. 6, 2024 – The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study published online Sept. 3 in Modern Rheumatology. ...

Causal Link Seen for High Ferritin, Serum Iron With Lower Risk for RA

WEDNESDAY, Sept. 4, 2024 – Genetic predisposition to high ferritin and serum iron status is associated with a lower risk for developing rheumatoid arthritis (RA), according to a study published...

High-Intensity Interval Training, Strength Exercise Beneficial in RA

TUESDAY, Sept. 3, 2024 – For patients with rheumatoid arthritis, high-intensity interval training (HIIT) and strength exercise are beneficial for cardiovascular health, physical fitness, and overall...

FDA Approves Tyenne (tocilizumab-aazg), a Biosimilar to Actemra

March 7, 2024 – Fresenius Kabi, a global health care company that specializes in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic...

FDA Approves Simlandi (adalimumab-ryvk), an Interchangeable Biosimilar to Humira

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) – Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...

FDA Grants Interchangeable Designation to Pfizer’s Biosimilar Abrilada

NEW YORK, October 5, 2023 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has designated Abrilada™ (adalimumab-afzb) as an interchangeable biosimilar to Hum...

FDA Approves Tofidence (tocilizumab-bavi), a Biosimilar to Actemra

CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) – Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved Tofidence (tocilizumab-bavi) intravenous...

FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira

JERSEY CITY, N.J.--(BUSINESS WIRE) May 24, 2023 --Celltrion USA today announced that the U.S. Food and Drug Administration (FDA) has approved Yuflyma® (adalimumab-aaty), a high-concentration ...

FDA Approves Riabni (rituximab-arrx), a Biosimilar to Rituxan (rituximab), for Adults with Moderate to Severe Rheumatoid Arthritis

THOUSAND OAKS, Calif., June 6, 2022 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Riabni (rituximab-arrx), a biosimilar to...

FDA Approves Yusimry (adalimumab-aqvh), a Biosimilar to Humira

REDWOOD CITY, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) – Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) announced that the United States Food and Drug Administration (“FDA”) appro...

FDA Approves Hulio (adalimumab-fkjp), a Biosimilar to Humira

HERTFORDSHIRE, England and PITTSBURGH and TOKYO, July 9, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the U.S. Food and Drug Admini...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Juvenile Rheumatoid Arthritis

Related drug support groups

prednisone, ibuprofen, naproxen, meloxicam, aspirin, doxycycline, Norco, diclofenac, methylprednisolone, view more... methotrexate, Vicodin, Humira, Celebrex, Aleve, Advil, Voltaren, triamcinolone, hydroxychloroquine, Motrin, Plaquenil, cortisone, Medrol, Enbrel, indomethacin, Mobic, Remicade, Lortab, Rituxan, Xeljanz, acetaminophen / hydrocodone, dexamethasone, adalimumab, Arthritis Pain, etanercept, glucosamine, rituximab, Actemra, tetracycline, nabumetone, garlic, Cimzia